The W.S. Badger Company, Inc

FDA inspection history across 2 sites, 2021 to 2023

2
Form 483s
1
Warning letter

Every document, by year

  • Form 483
  • Warning letter

2021: one Form 483; 2022: one warning letter; 2023: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2021–23Two Form 483s and one warning letter, at GILSUM, New Hampshire and Gilsum, New Hampshire.
  2. 2023The longest 483 on file: 11 observations over 14 pages at Gilsum, New Hampshire.

Cited most

Across all The W.S. Badger Company observations on file

The complete The W.S. Badger Company file.

All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$297

The price of the documents, added to your cart together

Sites

Documents

3 on file, newest first
DateDocumentPrice
2023-06-01483 Form 483$99
2022-04-12Warning letter Warning letter$99
2021-09-14483 Form 483$99

Investigators on these documents

Daniel L. Zheng (1)Lori M. Newman (1)

FEI number 3009946959 · most recent document Jun 1, 2023

About The W.S. Badger Company, Inc

How many FDA Form 483s has The W.S. Badger Company, Inc received?

FDA Intel has 2 Form 483s on file for The W.S. Badger Company, Inc; the most recent is dated Jun 1, 2023.

When was The W.S. Badger Company, Inc last inspected by FDA?

The most recent FDA inspection document on file for The W.S. Badger Company, Inc is a Form 483 dated Jun 1, 2023, for the site in Gilsum, New Hampshire.

What did FDA cite at The W.S. Badger Company, Inc?

The regulations cited most in the observations on file for The W.S. Badger Company, Inc are 21 CFR 211.160(a) (General requirements), 4 times; 21 CFR 211.192 (Production record review), 3 times; 21 CFR 211.166(a)(3) (Stability testing), 2 times.

Has The W.S. Badger Company, Inc received an FDA warning letter?

Yes. FDA Intel has 1 FDA warning letter on file for The W.S. Badger Company, Inc; the most recent is dated Apr 12, 2022.

The W.S. Badger Company, Inc FDA Inspection History & 483s · FDA Intel